See more : PT Asia Sejahtera Mina Tbk (AGAR.JK) Income Statement Analysis – Financial Results
Complete financial analysis of Greenway Greenhouse Cannabis Corporation (GWAY.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Greenway Greenhouse Cannabis Corporation, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Jiangsu Kuangshun Photosensitivity New-Material Stock Co., Ltd. (300537.SZ) Income Statement Analysis – Financial Results
- Jindal Cotex Limited (JINDCOT.NS) Income Statement Analysis – Financial Results
- Pyrophyte Acquisition Corp. WT (PHYT-WT) Income Statement Analysis – Financial Results
- Rederiaktiebolaget Gotland (publ) (GOTL-A.ST) Income Statement Analysis – Financial Results
- Apollo Global Management, Inc. (AAM-PA) Income Statement Analysis – Financial Results
Greenway Greenhouse Cannabis Corporation (GWAY.CN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.greenway.ca
About Greenway Greenhouse Cannabis Corporation
Greenway Greenhouse Cannabis Corporation engages in the cultivation, processing, and selling of dried cannabis flower and kief. The company was incorporated in 2018 and is based in Kingsville, Canada. Greenway Greenhouse Cannabis Corporation is a subsidiary of Sunrite Greenhouses Ltd.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 5.23M | 5.62M | 1.98M | 0.00 | 0.00 |
| Cost of Revenue | 5.57M | 4.88M | 1.14M | -487.88K | 465.32K |
| Gross Profit | -335.38K | 741.99K | 844.02K | 487.88K | -465.32K |
| Gross Profit Ratio | -6.41% | 13.20% | 42.53% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 47.28K | 10.93K | 0.00 |
| General & Administrative | 2.28M | 2.32M | 1.50M | 1.06M | 861.45K |
| Selling & Marketing | 223.71K | 241.24K | 203.65K | 30.86K | 41.55K |
| SG&A | 2.50M | 2.56M | 1.70M | 1.09M | 1.61M |
| Other Expenses | 1.04M | 187.50K | 250.00K | 250.00K | 0.00 |
| Operating Expenses | 3.54M | 2.79M | 2.29M | 1.73M | 1.61M |
| Cost & Expenses | 9.11M | 7.67M | 3.43M | 1.24M | 2.08M |
| Interest Income | 0.00 | 882.34K | 850.36K | 239.08K | 143.56K |
| Interest Expense | 843.57K | 882.34K | 850.36K | 239.08K | 143.56K |
| Depreciation & Amortization | 1.67M | 1.09M | 713.30K | 515.95K | 465.32K |
| EBITDA | -2.21M | -632.92K | -1.36M | -727.12K | -1.57M |
| EBITDA Ratio | -42.22% | -12.77% | 7.39% | 0.00% | 0.00% |
| Operating Income | -3.88M | -2.10M | -2.32M | -1.24M | -2.08M |
| Operating Income Ratio | -74.17% | -37.43% | -117.05% | 0.00% | 0.00% |
| Total Other Income/Expenses | -843.57K | -501.36K | -600.36K | 10.92K | -104.39K |
| Income Before Tax | -4.72M | -2.61M | -2.92M | -1.23M | -2.18M |
| Income Before Tax Ratio | -90.30% | -46.35% | -147.30% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 1.07M | 1.73M | 239.08K | -5.00 |
| Net Income | -4.72M | -2.61M | -2.92M | -1.23M | -2.18M |
| Net Income Ratio | -90.30% | -46.35% | -147.30% | 0.00% | 0.00% |
| EPS | -0.04 | -0.02 | -0.02 | -0.01 | -0.02 |
| EPS Diluted | -0.04 | -0.02 | -0.02 | -0.01 | -0.02 |
| Weighted Avg Shares Out | 118.07M | 130.92M | 129.91M | 121.63M | 121.63M |
| Weighted Avg Shares Out (Dil) | 116.02M | 130.92M | 129.91M | 121.63M | 121.63M |
Source: https://incomestatements.info
Category: Stock Reports